The Knudson "two-hit" hypothesis has provided the rationale for studies that aim to identify tumor-suppressor genes by mapping regions of allelic loss (loss of heterozygosity, LOH). Although LOH has been found in practically all types of tumors, very few such projects have been successful in identifying their tumor-suppressor targets. The prime explanation for this failure is probably that researchers have, in general, been too credulous about the two-hit hypothesis, and too willing to ignore factors such as intratumor heterogeneity, contamination by normal cells, karyotypic complexity, homozygous deletions, gene dosage changes, and polymerase chain reaction artifacts. We suggest ways of minimizing these problems. Unfortunately, there is no...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Item does not contain fulltextHuman Leukocyte Antigen (HLA) class I molecules are essential for tumo...
The analysis of loss of heterozygosity (LOH) in tumours can be used to map candidate sites of tumour...
The Knudson "two-hit" hypothesis has provided the rationale for studies that aim to identify tumor-s...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
BACKGROUND: Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is kno...
Loss of heterozygosity (LOH) is a common genetic event in the development of cancer. In certain tumo...
Identifying regions of loss-of-heterozygosity (LOH) in a tumor sample is a challenging problem. Stat...
Identifying regions of loss-of-heterozygosity (LOH) in a tumor sample is a challenging problem. Stat...
Somatic loss of heterozygosity (LOH) has been widely reported in breast cancer as a means of identif...
Loss of heterozygosity (LOH) of chromosomal regions bearing tumor suppressors is a key event in the ...
Loss of heterozygosity (LOH) is a common genetic lesion found in many human neoplasms. Extending inv...
Background Loss of heterozygosity (LOH) is an important marker for one of the 'two-hits' required fo...
Somatic loss of heterozygosity (LOH) has been widely reported in breast cancer as a means of identif...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Item does not contain fulltextHuman Leukocyte Antigen (HLA) class I molecules are essential for tumo...
The analysis of loss of heterozygosity (LOH) in tumours can be used to map candidate sites of tumour...
The Knudson "two-hit" hypothesis has provided the rationale for studies that aim to identify tumor-s...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
BACKGROUND: Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is kno...
Loss of heterozygosity (LOH) is a common genetic event in the development of cancer. In certain tumo...
Identifying regions of loss-of-heterozygosity (LOH) in a tumor sample is a challenging problem. Stat...
Identifying regions of loss-of-heterozygosity (LOH) in a tumor sample is a challenging problem. Stat...
Somatic loss of heterozygosity (LOH) has been widely reported in breast cancer as a means of identif...
Loss of heterozygosity (LOH) of chromosomal regions bearing tumor suppressors is a key event in the ...
Loss of heterozygosity (LOH) is a common genetic lesion found in many human neoplasms. Extending inv...
Background Loss of heterozygosity (LOH) is an important marker for one of the 'two-hits' required fo...
Somatic loss of heterozygosity (LOH) has been widely reported in breast cancer as a means of identif...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Item does not contain fulltextHuman Leukocyte Antigen (HLA) class I molecules are essential for tumo...
The analysis of loss of heterozygosity (LOH) in tumours can be used to map candidate sites of tumour...